Tim Cp Somervaille

13PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersClinical pharmacology and therapeuticsGene and molecular therapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 25, 2023
A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.

Lucy Ginn, Joe Maltas, Martin J Baker

|Mar 07, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca

|Feb 18, 2022
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.

Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille

|Dec 04, 2021
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML.

Luciano Nicosia, Francesca Ludovica Boffo, Elena Ceccacci

Pageof 3